EUR 11.94
(5.29%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 18.81 Million EUR | 2.62% |
2022 | 18.32 Million EUR | 147.62% |
2021 | 7.4 Million EUR | 33.97% |
2020 | 5.52 Million EUR | -43.39% |
2019 | 9.75 Million EUR | 125.57% |
2018 | 4.32 Million EUR | 4.66% |
2017 | 4.13 Million EUR | 230.37% |
2016 | -3.17 Million EUR | -1871.35% |
2015 | -160.86 Thousand EUR | -385.03% |
2014 | -33.16 Thousand EUR | 79.92% |
2013 | -165.16 Thousand EUR | 18.95% |
2012 | -203.78 Thousand EUR | 0.0% |
2011 | - EUR | 0.0% |
2010 | - EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 3.99 Million EUR | 63.54% |
2024 Q2 | 2.41 Million EUR | -39.5% |
2023 Q4 | 2.44 Million EUR | -65.63% |
2023 Q3 | 7.1 Million EUR | 60.09% |
2023 FY | 18.81 Million EUR | 2.62% |
2023 Q1 | 4.82 Million EUR | 94.87% |
2023 Q2 | 4.43 Million EUR | -8.12% |
2022 Q1 | 5.03 Million EUR | 302.49% |
2022 Q2 | 4.93 Million EUR | -2.06% |
2022 FY | 18.32 Million EUR | 147.62% |
2022 Q3 | 5.87 Million EUR | 19.15% |
2022 Q4 | 2.47 Million EUR | -57.85% |
2021 Q3 | 3.61 Million EUR | 5.39% |
2021 Q1 | 2.84 Million EUR | 58.27% |
2021 Q4 | -2.48 Million EUR | -168.79% |
2021 FY | 7.4 Million EUR | 33.97% |
2021 Q2 | 3.43 Million EUR | 20.8% |
2020 Q3 | 1.1 Million EUR | 28.17% |
2020 Q2 | 859 Thousand EUR | -62.81% |
2020 Q1 | 2.31 Million EUR | 28.2% |
2020 Q4 | 1.79 Million EUR | 63.03% |
2020 FY | 5.52 Million EUR | -43.39% |
2019 Q3 | 3.98 Million EUR | 91.77% |
2019 Q1 | 1.98 Million EUR | 41.79% |
2019 FY | 9.75 Million EUR | 125.57% |
2019 Q4 | 1.8 Million EUR | -54.81% |
2019 Q2 | 2.07 Million EUR | 4.71% |
2018 Q3 | 1.4 Million EUR | 83.5% |
2018 FY | 4.32 Million EUR | 4.66% |
2018 Q2 | 763.11 Thousand EUR | 0.0% |
2018 Q1 | 763.11 Thousand EUR | -1.51% |
2018 Q4 | 1.4 Million EUR | 0.0% |
2017 FY | 4.13 Million EUR | 230.37% |
2017 Q1 | 1.29 Million EUR | 156.01% |
2017 Q2 | 1.29 Million EUR | 0.0% |
2017 Q3 | 774.85 Thousand EUR | -40.04% |
2017 Q4 | 774.85 Thousand EUR | 0.0% |
2016 Q4 | -2.3 Million EUR | 0.0% |
2016 Q1 | 721.79 Thousand EUR | 0.0% |
2016 Q2 | 721.79 Thousand EUR | -0.0% |
2016 Q3 | -2.3 Million EUR | -419.68% |
2016 FY | -3.17 Million EUR | -1871.35% |
2015 FY | -160.86 Thousand EUR | -385.03% |
2014 FY | -33.16 Thousand EUR | 79.92% |
2013 FY | -165.16 Thousand EUR | 18.95% |
2012 FY | -203.78 Thousand EUR | 0.0% |
2011 FY | - EUR | 0.0% |
2010 FY | - EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Cegedim SA | -7.4 Million EUR | 353.949% |
Guerbet SA | 23.86 Million EUR | 21.185% |
Nexus AG | 24.03 Million EUR | 21.726% |
Bastide Le Confort Médical SA | -900 Thousand EUR | 2190.0% |
Revenio Group Oyj | 19.1 Million EUR | 1.565% |
Drägerwerk AG & Co. KGaA | 110.43 Million EUR | 82.967% |
Sartorius Aktiengesellschaft | 205.2 Million EUR | 90.833% |
LNA Santé SA | 23.4 Million EUR | 19.646% |
Siemens Healthineers AG | 1.94 Billion EUR | 99.031% |
Equasens Société anonyme | 47.04 Million EUR | 60.019% |
Stratec SE | 13.06 Million EUR | -43.95% |